| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S1550-8579(07)80026-X |
| P698 | PubMed publication ID | 17707846 |
| P2093 | author name string | Inge Loy-English | |
| Nahid A Azad | |||
| Muneerah Al Bugami | |||
| P2860 | cites work | Gender differences in the incidence of AD and vascular dementia: The EURODEM Studies | Q22241634 |
| Convergence of atherosclerosis and Alzheimer's disease: inflammation, cholesterol, and misfolded proteins | Q28168105 | ||
| Warfarin and aspirin use and the predictors of major bleeding complications in atrial fibrillation (the Framingham Heart Study) | Q28214210 | ||
| MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial | Q28214393 | ||
| Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium | Q28252389 | ||
| Midlife vascular risk factors and Alzheimer's disease in later life: longitudinal, population based study | Q28366850 | ||
| Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition | Q29615691 | ||
| Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial | Q29617817 | ||
| Sex differences in the clinical presentation, resource use, and 3-month outcome of acute stroke in Europe: data from a multicenter multinational hospital-based registry | Q30784702 | ||
| Decreased prevalence of Alzheimer disease associated with 3-hydroxy-3-methyglutaryl coenzyme A reductase inhibitors. | Q33921362 | ||
| Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study | Q33941073 | ||
| Plasma homocysteine as a risk factor for dementia and Alzheimer's disease | Q33957399 | ||
| An 18-year follow-up of overweight and risk of Alzheimer disease | Q34214251 | ||
| Effects of estrogen on congnition mood, and degenerative brain diseases. | Q34215588 | ||
| A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study | Q34225539 | ||
| Effects of moderate alcohol consumption on cognitive function in women | Q34386016 | ||
| The metabolic syndrome and Alzheimer disease. | Q53284115 | ||
| Alzheimer's disease – a vascular dementia? | Q57947792 | ||
| Low-Density Lipoprotein Cholesterol and the Risk of Dementia With Stroke | Q61881937 | ||
| Type 2 diabetes mellitus and cognition: an understudied issue in women's health | Q78944637 | ||
| Homocysteine lowering and cognitive performance | Q79150062 | ||
| Comparison of the impact of atrial fibrillation on the risk of stroke and cardiovascular death in women versus men (The Copenhagen City Heart Study) | Q80820976 | ||
| Alzheimer's disease and Parkinson's disease | Q35097797 | ||
| Cardiovascular risk factors and Alzheimer's disease | Q35801866 | ||
| Risk factors for vascular dementia and Alzheimer disease | Q35890957 | ||
| Diabetes in the elderly and in women: cardiovascular risks | Q35926398 | ||
| Vascular factors in dementia: an overview | Q35945382 | ||
| Gender differences in Alzheimer disease: the role of luteinizing hormone in disease pathogenesis | Q36155121 | ||
| The age-dependent relation of blood pressure to cognitive function and dementia | Q36201875 | ||
| Homocysteine, estrogen and cognitive decline. | Q36477867 | ||
| Is the cognitive function of older patients affected by antihypertensive treatment? Results from 54 months of the Medical Research Council's trial of hypertension in older adults | Q36598021 | ||
| Use of ramipril in preventing stroke: double blind randomised trial | Q39524006 | ||
| Estrogen use, APOE, and cognitive decline: evidence of gene-environment interaction | Q41737310 | ||
| Apolipoprotein-E gene polymorphism and lipid profiles in Alzheimer's disease | Q43574845 | ||
| The impact of APOE on myocardial infarction, stroke, and dementia: the Rotterdam Study | Q43783041 | ||
| The prevention of dementia with antihypertensive treatment: new evidence from the Systolic Hypertension in Europe (Syst-Eur) study | Q44175666 | ||
| The Study on Cognition and Prognosis in the Elderly (SCOPE): principal results of a randomized double-blind intervention trial | Q44417511 | ||
| Plasma total cholesterol level as a risk factor for Alzheimer disease: the Framingham Study | Q44438334 | ||
| Effects of blood pressure lowering with perindopril and indapamide therapy on dementia and cognitive decline in patients with cerebrovascular disease | Q44438340 | ||
| Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial | Q44456433 | ||
| Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial | Q44456435 | ||
| Major risk factors as antecedents of fatal and nonfatal coronary heart disease events | Q44556056 | ||
| Effect of smoking on global cognitive function in nondemented elderly. | Q44596659 | ||
| Sex differences in genetic risk for dementia | Q44631588 | ||
| Homocysteine is a risk factor for cerebral small vessel disease, acting via endothelial dysfunction | Q44649021 | ||
| A 2-year follow-up study of cigarette smoking and risk of dementia | Q44828259 | ||
| Conjugated equine estrogens and global cognitive function in postmenopausal women: Women's Health Initiative Memory Study | Q44948891 | ||
| The metabolic syndrome, inflammation, and risk of cognitive decline | Q45145786 | ||
| Association between reported alcohol intake and cognition: results from the Women's Health Initiative Memory Study | Q45238753 | ||
| Light to moderate alcohol consumption is associated with better cognitive function among older male veterans receiving primary care | Q45332754 | ||
| A 24-year follow-up of body mass index and cerebral atrophy | Q46236540 | ||
| The prevalence and severity of white matter lesions, their relationship with age, ethnicity, gender, and cardiovascular disease risk factors: the ARIC Study | Q46362721 | ||
| Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial | Q46412589 | ||
| Education and APOE-e4 in longitudinal cognitive decline: MacArthur Studies of Successful Aging | Q46467641 | ||
| High total cholesterol levels in late life associated with a reduced risk of dementia. | Q46505847 | ||
| Statins and cognitive function in the elderly: the Cardiovascular Health Study | Q46794954 | ||
| Sex, apolipoprotein E epsilon 4 status, and hippocampal volume in mild cognitive impairment | Q46819942 | ||
| Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study | Q47887017 | ||
| Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks | Q48238616 | ||
| Sex differences in the clinical manifestations of Alzheimer disease pathology | Q48866213 | ||
| Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study | Q48958955 | ||
| Blood pressure and risk of dementia: results from the Rotterdam study and the Gothenburg H-70 Study | Q49138742 | ||
| Age-specific incidence of Alzheimer's disease in a community population. | Q50596369 | ||
| Atrial fibrillation and dementia in a population-based study. The Rotterdam Study. | Q50972617 | ||
| Low blood pressure and the risk of dementia in very old individuals. | Q51944569 | ||
| Low blood pressure and risk of dementia in the Kungsholmen project: a 6-year follow-up study. | Q51950626 | ||
| Is diabetes associated with cognitive impairment and cognitive decline among older women? Study of Osteoporotic Fractures Research Group. | Q51977974 | ||
| Plasma C peptide level and cognitive function among older women without diabetes mellitus. | Q51990094 | ||
| P433 | issue | 2 | |
| P921 | main subject | dementia | Q83030 |
| P304 | page(s) | 120-129 | |
| P577 | publication date | 2007-06-01 | |
| P1433 | published in | Gender Medicine | Q15816303 |
| P1476 | title | Gender differences in dementia risk factors | |
| P478 | volume | 4 |
| Q90642133 | Age-specific differences in gait domains and global cognitive function in older women: gait characteristics based on gait speed modification |
| Q92743318 | Analysis of dementia in the US population using Medicare claims: Insights from linked survey and administrative claims data |
| Q37070957 | Apolipoprotein polymorphism is associated with pro-thrombotic profile in non-demented dyslipidemic subjects |
| Q92934873 | Association of Estradiol and Visceral Fat With Structural Brain Networks and Memory Performance in Adults |
| Q92150115 | Associations Among Health Insurance Type, Cardiovascular Risk Factors, and the Risk of Dementia: A Prospective Cohort Study in Korea |
| Q33693268 | Brain sex matters: estrogen in cognition and Alzheimer's disease |
| Q38879090 | Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease |
| Q35776248 | Characterization of cognitive deficits in spontaneously hypertensive rats, accompanied by brain insulin receptor dysfunction |
| Q37571623 | Chronic stress- and sex-specific neuromorphological and functional changes in limbic structures |
| Q48788973 | Clinical progression of moderate-to-severe Alzheimer's disease and caregiver burden: a 12-month multicenter prospective observational study |
| Q45786403 | Cognitive impairment and depression in the early 60s: which is more problematic in terms of instrumental activities of daily living? |
| Q35043834 | Cognitive impairment, depression, comorbidity of the two and associated factors among the early sixties in a rural Korean community |
| Q34519968 | Correlates of cognitive impairment in older Vietnamese |
| Q85961131 | Cortisol, HDL-c, VLDL-c, and APOE Polymorphisms as Laboratorial Parameters Associated to Cognitive Impairment No Dementia (CIND) and Dementia |
| Q59050417 | Demographic and Clinical Characteristics of Patients with Dementia in Greece |
| Q39390891 | Differences Between Men and Women Aged 65 and Older in the Relationship Between Self-Reported Sleep and Cognitive Impairment: A Nationwide Survey in Taiwan |
| Q64108606 | Effect of late-life weight change on dementia incidence: a 10-year cohort study using claim data in Korea |
| Q37339094 | Elevated C-reactive protein levels are associated with prevalent dementia in the oldest-old |
| Q21136190 | Evidence for sub-haplogroup h5 of mitochondrial DNA as a risk factor for late onset Alzheimer's disease |
| Q90211026 | Gender and Educational Differences in the Association between Lifestyle and Cognitive Decline over 10 Years: The Doetinchem Cohort Study |
| Q38993591 | Gender-Specific Degeneration of Dementia-Related Subcortical Structures Throughout the Lifespan |
| Q37345005 | Gender-Specific Incidence and Predictors of Cognitive Impairment among Older Koreans: Findings from a 6-Year Prospective Cohort Study. |
| Q33659542 | Gender-specific impact of personal health parameters on individual brain aging in cognitively unimpaired elderly subjects |
| Q35996424 | Genetic polymorphisms of nerve growth factor receptor (NGFR) and the risk of Alzheimer's disease. |
| Q35094704 | Genetics of Vascular Dementia |
| Q37814804 | Geropsychology: the gender gap in human aging--a mini-review |
| Q33794469 | Hypertension increases the probability of Alzheimer's disease and of mild cognitive impairment in an Arab community in northern Israel. |
| Q37551271 | Hypertension, dementia, and antihypertensive treatment: implications for the very elderly. |
| Q45853888 | Incidence of dementia: evidence for an effect modification by gender. The ILSA Study |
| Q28390996 | Increased Risk of Dementia in Patients With Acute Organophosphate and Carbamate Poisoning: A Nationwide Population-Based Cohort Study |
| Q64247539 | Increased risk of neurodegenerative dementia in women with migraines: A nested case-control study using a national sample cohort |
| Q35025811 | Kidney function and cognitive performance and decline in older men. |
| Q37182239 | Locating sex-specific evidence on clinical questions in MEDLINE: a search filter for use on OvidSP |
| Q37337930 | Mapping the effect of APOE epsilon4 on gray matter loss in Alzheimer's disease in vivo |
| Q90571674 | Marital status and cognitive impairment in the United States: evidence from the National Health and Aging Trends Study |
| Q35137488 | Reduction of β-amyloid and γ-secretase by calorie restriction in female Tg2576 mice |
| Q36425967 | Reproductive life events and Alzheimer's disease in Italian women: a retrospective study. |
| Q45277488 | Sedative use and incident cognitive decline among persons aged 75 years and older: a population-based longitudinal study |
| Q38783417 | Sex differences in metabolic risk indicator of dementia in an elderly urban Korean population: A community-based cross-sectional study. |
| Q35126449 | Sex differences in the inflammatory response of primary astrocytes to lipopolysaccharide |
| Q38471576 | Sex differences in the injured brain. |
| Q47814894 | Speaking one more language in early life has only minor effects on cognition in Taiwanese with low education level: the Taishan Project |
| Q36253078 | The association between systemic inflammation and cognitive performance in the elderly: the Sydney Memory and Ageing Study |
| Q36942402 | The effect of increased genetic risk for Alzheimer's disease on hippocampal and amygdala volume |
| Q37493067 | The sex-specific associations of the aromatase gene with Alzheimer's disease and its interaction with IL10 in the Epistasis Project |
| Q93009945 | The synthetic steroid tibolone exerts sex-specific regulation of astrocyte phagocytosis under basal conditions and after an inflammatory challenge |
| Q89119354 | Understanding the impact of sex and gender in Alzheimer's disease: A call to action |
| Q35133129 | Variations in apolipoprotein E frequency with age in a pooled analysis of a large group of older people |
| Q36069430 | Women have farther to fall: gender differences between normal elderly and Alzheimer's disease in verbal memory engender better detection of Alzheimer's disease in women |
Search more.